134 related articles for article (PubMed ID: 28498028)
1. miR-337 can be a key negative regulator in melanoma.
Xiao W; Yao E; Zheng W; Tian F; Tian L
Cancer Biol Ther; 2017 Jun; 18(6):392-399. PubMed ID: 28498028
[TBL] [Abstract][Full Text] [Related]
2. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
[TBL] [Abstract][Full Text] [Related]
3. miR-4262 promotes the proliferation of human cutaneous malignant melanoma cells through KLF6-mediated EGFR inactivation and p21 upregulation.
Zhang D; Li Z; Zhang Y; Tu C; Huo J; Liu Y
Oncol Rep; 2016 Dec; 36(6):3657-3663. PubMed ID: 27779691
[TBL] [Abstract][Full Text] [Related]
4. STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells.
Cheng Y; Li Y; Nian Y; Liu D; Dai F; Zhang J
BMC Cancer; 2015 Apr; 15():306. PubMed ID: 25928665
[TBL] [Abstract][Full Text] [Related]
5. miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression.
Song H; Tao Y; Ni N; Zhou X; Xiong J; Zeng X; Xu X; Qi J; Sun J
J Dermatol Sci; 2018 Sep; 91(3):317-324. PubMed ID: 30025750
[TBL] [Abstract][Full Text] [Related]
6. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
Guo H; Cheng Y; Martinka M; McElwee K
Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-21 regulates the ERK/NF-κB signaling pathway to affect the proliferation, migration, and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN.
Mao XH; Chen M; Wang Y; Cui PG; Liu SB; Xu ZY
Mol Carcinog; 2017 Mar; 56(3):886-894. PubMed ID: 27533779
[TBL] [Abstract][Full Text] [Related]
8. MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2.
Luo C; Merz PR; Chen Y; Dickes E; Pscherer A; Schadendorf D; Eichmüller SB
Cancer Lett; 2013 Dec; 341(2):240-7. PubMed ID: 23962556
[TBL] [Abstract][Full Text] [Related]
9. miR-579-3p controls melanoma progression and resistance to target therapy.
Fattore L; Mancini R; Acunzo M; Romano G; Laganà A; Pisanu ME; Malpicci D; Madonna G; Mallardo D; Capone M; Fulciniti F; Mazzucchelli L; Botti G; Croce CM; Ascierto PA; Ciliberto G
Proc Natl Acad Sci U S A; 2016 Aug; 113(34):E5005-13. PubMed ID: 27503895
[TBL] [Abstract][Full Text] [Related]
10. miR-337 suppresses cutaneous T-cell lymphoma via the STAT3 pathway.
Xia L; Wu L; Xia H; Bao J; Li Q; Chen X; Xia R
Cell Cycle; 2019 Jul; 18(14):1635-1645. PubMed ID: 31213131
[TBL] [Abstract][Full Text] [Related]
11. Expression of miR-203 is decreased and associated with the prognosis of melanoma patients.
Wang K; Zhang ZW
Int J Clin Exp Pathol; 2015; 8(10):13249-54. PubMed ID: 26722525
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic identification of miR-205 target genes potentially involved in metastasis and survival of cutaneous malignant melanoma.
Sánchez-Sendra B; Serna E; Navarro L; González-Muñoz JF; Portero J; Ramos A; Murgui A; Monteagudo C
Sci Rep; 2020 Mar; 10(1):4771. PubMed ID: 32179834
[TBL] [Abstract][Full Text] [Related]
13. MiR-769 promoted cell proliferation in human melanoma by suppressing GSK3B expression.
Qiu HJ; Lu XH; Yang SS; Weng CY; Zhang EK; Chen FC
Biomed Pharmacother; 2016 Aug; 82():117-23. PubMed ID: 27470346
[TBL] [Abstract][Full Text] [Related]
14. miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes.
Luo C; Tetteh PW; Merz PR; Dickes E; Abukiwan A; Hotz-Wagenblatt A; Holland-Cunz S; Sinnberg T; Schittek B; Schadendorf D; Diederichs S; Eichmüller SB
J Invest Dermatol; 2013 Mar; 133(3):768-775. PubMed ID: 23151846
[TBL] [Abstract][Full Text] [Related]
15. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.
Dynoodt P; Speeckaert R; De Wever O; Chevolet I; Brochez L; Lambert J; Van Gele M
Int J Oncol; 2013 Apr; 42(4):1443-51. PubMed ID: 23404256
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA HEIH promotes melanoma cell proliferation, migration and invasion via inhibition of
Zhao H; Xing G; Wang Y; Luo Z; Liu G; Meng H
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28487474
[TBL] [Abstract][Full Text] [Related]
17. ADAR1-mediated regulation of melanoma invasion.
Nemlich Y; Baruch EN; Besser MJ; Shoshan E; Bar-Eli M; Anafi L; Barshack I; Schachter J; Ortenberg R; Markel G
Nat Commun; 2018 May; 9(1):2154. PubMed ID: 29855470
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA ILF3-AS1 promotes cell proliferation, migration, and invasion via negatively regulating miR-200b/a/429 in melanoma.
Chen X; Liu S; Zhao X; Ma X; Gao G; Yu L; Yan D; Dong H; Sun W
Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28935763
[TBL] [Abstract][Full Text] [Related]
19. MiR-431 is a prognostic marker and suppresses cell growth, migration and invasion by targeting NOTCH2 in melanoma.
Sun YW; Li XH; Wang H; Wu J
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3876-3884. PubMed ID: 31115015
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA H19 promotes glucose metabolism and cell growth in malignant melanoma via miR-106a-5p/E2F3 axis.
Luan W; Zhou Z; Ni X; Xia Y; Wang J; Yan Y; Xu B
J Cancer Res Clin Oncol; 2018 Mar; 144(3):531-542. PubMed ID: 29350287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]